Skip to content
Research Article Open access CC BY 4.0

Tocotrienol-rich Fraction Modulated Genes Responsible for Inflammation in Lipopolysaccharide-stimulated RAW 264.7 Macrophages

Sitti Rahma Abd Hafid, Maliya Azilah Mohammad Aini, Nabiha Iran, Irmaliayana Norisam, Khairul Adzfa Radzun, Ammu Kutty Radhakrishnan

Journal of Pharmaceutical Research International · pp. 106–118 · Published 11 Dec 2021

10.9734/jpri/2021/v33i54B33771

Abstract

Background: Inflammation plays a vital role in the pathogenesis of chronic non-communicable diseases (NCDs), the leading health issue worldwide. An earlier study reported that tocotrienol-rich fraction (TRF) showed better anti-inflammation effects in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Aim: This study aimed to investigate the anti-inflammatory effects of tocotrienol-rich fraction at the molecular level by looking at the genes that were differentially regulated and pathways affected in LPS-stimulated macrophages exposed to TRF using the microarray approach. Methods: A microarray study was carried out in LPS-stimulated RAW 264.7 macrophages. Total ribonucleic acid (RNA) was extracted from the RAW 264.7 cells treated with TRF (10µg/mL), alpha-tocopherol (10 µg/mL) or LPS (10 ng/mL). Untreated cells served as control. Enrichment analyses, such as Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG), were conducted for genes listed in the differentially expressed genes (DEGs).  Results: The microarray analysis showed that the expression of five genes [Hamp, Interleukin-1a (IL-1a), IL-b, C-X-C motif chemokine ligand 2 (CXCL2) and colony-stimulating factor 3 (CSF3)] and one gene (SLC1A4), an amino acid transporter, was modulated (fold change 2, P< 0.05) in the TRF-treated cells. With a more stringent analysis (fold change 3, P < 0.05), only one gene (CSF3) was downregulated in the TRF-treated in RAW 264.7 cells. Analysis using the GO and KEGG pathways revealed interactions between pro-inflammatory agents such as tumor necrosis factor-alpha (TNFα) and nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-B), as well as signaling pathways of interleukin (IL)-1 and IL-17. Conclusion: TRF modulated the expression of genes responsible for acute and chronic inflammation that were part of the lipoxygenase (LOX) and cyclooxygenase (COX) inflammatory pathways. Further investigation on the effects of TRF in different cell lines and in vivo studies should be conducted in the future.

Tocotrienol-rich fraction (TRF) inflammatory response macrophages gene regulation ontology KEGG pathway

References (32)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 Inflammatory responses and inflammation-associated diseases in organs [DOI]
  3. 3 Chronic inflammation in the etiology of disease across the life span [DOI]
  4. 4 Overview of the IL ‐1 family in innate inflammation and acquired immunity [DOI]
  5. 5 Regulation of NF-κB by TNF family cytokines [DOI]
  6. 6 A guiding map for inflammation [DOI]
  7. 7 IL-17 Signaling: The Yin and the Yang [DOI]
  8. 8 The roles of IL‐17A in inflammatory immune responses and host defense against pathogens [DOI]
  9. 9 T-helper 1 cells facilitate the entry of T-helper 17 cells to the central nervous system during experimental autoimmune encephalomyelitis [DOI]
  10. 10 Regulatory role of vitamin E in the immune system and inflammation [DOI]
  11. 11 Structural Basis of IL-1 Family Cytokine Signaling [DOI]
  12. 12 Hepcidin regulation by innate immune and infectious stimuli [DOI]
  13. 13 Review of Anti-Inflammatory Herbal Medicines [DOI]
  14. 14 The role of iron homeostasis in remodeling immune function and regulating inflammatory disease [DOI]
  15. 15 Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-κB Activation through Inhibition of Activation of IκBα Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis [DOI]
  16. 16 Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-κB pathways [DOI]
  17. 17 The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis [DOI]
  18. 18 Resveratrol inhibits LPS‑induced inflammation through suppressing the signaling cascades of TLR4‑NF‑κB/MAPKs/IRF3 [DOI]
  19. 19 Tocotrienols Suppress Proinflammatory Markers and Cyclooxygenase‐2 Expression in RAW264.7 Macrophages [DOI]
  20. 20 Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination [DOI]
  21. 21 Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities [DOI]
  22. 22 L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction [DOI]
  23. 23 Lipopolysaccharide induces CXCL2/macrophage inflammatory protein‐2 gene expression in enterocytes via NF‐κB activation: independence from endogenous TNF‐α and platelet‐activating factor [DOI]
  24. 24 Beneficial effects of δ-tocotrienol against oxidative stress in osteoblastic cells: studies on the mechanisms of action [DOI]
  25. 25 Tocotrienols Modulate a Life or Death Decision in Cancers [DOI]
  26. 26 Oxidative Stress Status and Neuroprotection of Tocotrienols in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration Rat Animal Model [DOI]
  27. 27 Tocotrienols are good adjuvants for developing cancer vaccines [DOI]
  28. 28 Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer [DOI]
  29. 29 Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis [DOI]
  30. 30 Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the SATB1 Gene in Murine Breast Cancer Cells and Tissues [DOI]
  31. 31 Application of palm tocotrienol adjuvanted dendritic cell in cancer therapy [DOI]
  32. 32 Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.